InvestorsHub Logo

biowin

04/22/23 8:35 AM

#133979 RE: MadScholar1 #133978

If we look back August 2017, Bioamber Sarnia purchased Mitsui's entire minority equity for $1, "the transaction is meaningful opportunity for Bioamber's shareholders" stated the COO Fabrice Orecchioni (which means??they had a plan to sell the company)
https://www.worldofchemicals.com/media/bioamber-buys-mitsui-equity-stake-in-sarnia-joint-venture/11825.html
In September 2017, new Ceo takes over Bioamber, Richard Eno, who had a position as vice president oil and gas sector ( was well familiar with DOE and about Bioamber's loan guarantee of 360M, I'm sure they discussed how to pull this off by using Visolis as an investment in Bioamber)
When Eno took over Bioamber, Deepak Dugar was already working with DOE and previously pwc and Eno had to know the plan with other executives and pwc that the investment in Bioamber was going to happen with DOE and KKR as they discussed and prepared with pwc (Bioamber wanted more investors (KKR) to add to the 360M because it wasn't enough to build the second plant (it was originally 500M agreed by Obama but Trump wanted a counter offer to make up the difference )) eg. Government or private)
So the only reason Mitsui agreed to give up his equity was to agree to the secret plan, merger into a second plant with the existing (confidentiality and security has to be in place just like other construction,) Mitsui is partners with Origin Materials and Lanzatech and visolis is really the DOE

toncatmad

04/22/23 8:51 AM

#133981 RE: MadScholar1 #133978

Well what did they speak about? Put up some links to back up your claims then. It makes no difference one way or the other but let’s see you back up those claims